Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
Nov 2, 2008By: Jill WechslerPharmaceutical TechnologyVolume 32, Issue 11, pp. 36-44
In the past three years, nanotechnology has gained prominence on the US Food and Drug Administration's regulatory and research agenda. The prospect that tiny materials may form effective, targeted medicines and improved versions of many FDA-regulated products has generated great enthusiasm among scientists and manufacturers. Some drugs that incorporate nanomaterials are already on the market, along with many over-the-counter sunscreens, cosmetics, dietary supplements, and food products.
Nanotechnology will be used in many products that come across FDA's threshold, according to the agency's senior scientist Richard Canady. FDA's challenge, Canady explained at a public meeting on nanotechnology in September 2008, is to determine whether products incorporating small particles pose new hazards and thus require new regulatory and testing policies.
To read more about this article make click here
Suscribirse a:
Enviar comentarios (Atom)
Entradas
Nanotechnology is the study of manipulating substance on an atomic and molecular level. Nanotechnology market products objective is to provide a clean, renewable energy from new materials in the world and also recover the health problem through the early recognition of diseases.Above report having great focus on development of nanotechnology in food and Drug industry..very useful and informative post Business Research
ResponderEliminar